Pfizer and Takeda allow Japan distribution deal for 13 drugs to lapse
This article was originally published in Scrip
Executive Summary
Takeda will halt the distribution of 13 Pfizer products in Japan from the end of this year, transferring them back to the US firm. The portfolio, which includes several ex-Wyeth drugs, all are manufactured by Pfizer and are currently exclusively distributed by Takeda.